IP Library Granted Patent US 9,511,153
Granted Patent B2
US 9,511,153 · App. 13/623,151 · Granted Dec 6, 2016

Loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,511,153
App. No.
13/623,151
Granted
Dec 6, 2016
Kind
B2
Abstract

Particles are provided for use in therapeutic and/or diagnostic procedures. The particles include poly[bis(trifluoroethoxy)phosphazene] and/or a derivatives thereof which may be present throughout the particles or within an outer coating of the particles. The particles can also include a core having a hydrogel formed from an acrylic-based polymer. Barium sulfate may also be provided to the core of the particles as a coating or absorbed within the core of the particles. The particles can be used to minimize blood flow to mammalian tissues by occluding at least a portion of a blood vessel of the mammal, or to deliver an active agent to a localized area within a body of a mammal by contacting a localized area with at least one of the particles. Further, the particles are useful in sustained release formulations including active agent(s) for oral administration, as tracer particles for injection into the bloodstream of a mammal or for use in enhanced ultrasound imaging. The particles may include agents for increasing density for achieving useful buoyancy levels in suspension.

Claims (4)

1. A method of tracing the passage of a particle through a blood vessel in a mammal, the method comprising injecting into the bloodstream of a mammal at least one tracer particle, the tracer particle comprising poly[bis(trifluoroethoxy)phosphazene] and/or a derivative thereof and a contrast agent, and imaging the route of the particle.

2. The method according to claim 1 , wherein the tracer particle comprises a core and a coating surrounding the core, wherein the coating comprises poly[bis(trifluoroethoxy)phosphazene] and/or a derivative thereof and the core comprises an acrylic-based polymer hydrogel.

3. The method according to claim 2 , wherein the particle core further comprises barium sulfate as coating and/or diffused within the core.

4. The method according to claim 1 , wherein the contrast agent is selected from the group consisting of barium sulfate, tantalum compounds, gadolinium compounds and iodine-containing compounds.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2020
From: BOSTON SCIENTIFIC CORPORATION
To: VARIAN MEDICAL SYSTEMS, INC.
Reel/Frame 051511/0504 →
NUNC PRO TUNC ASSIGNMENT Recorded Apr 24, 2019
From: CELONOVA BIOSCIENCES GERMANY GMBH
To: BOSTON SCIENTIFIC LIMITED
Reel/Frame 048981/0830 →